Description
Coligaz (Simeticone) Chewing Tablets 125 mg. №7
Ingredients
Active ingredient: Simeticone 125 mg per tablet.
Mechanism of Action
Simeticone acts as an anti-foaming agent by breaking down gas bubbles in the digestive system, facilitating their expulsion and providing relief from bloating and discomfort.
Pharmacological Properties
Simeticone is an inert silicone polymer that decreases surface tension and allows trapped gas in the gastrointestinal tract to coalesce, enabling easier passage and reducing symptoms of excess gas.
Indications for Use
Coligaz Chewing Tablets are indicated for the alleviation of bloating, discomfort, and pain associated with the accumulation of gas in the digestive tract.
Contraindications
Do not use:
- If allergic to simeticone or any other components of the product.
Side Effects
Common side effects may include mild gastrointestinal disturbances such as nausea or diarrhea. If any adverse reactions occur, discontinue use and seek medical advice.
Usage Instructions
Recommended Dosage:
- Adults and children over 12 years: Chew 1-2 tablets after meals and at bedtime as needed.
- Do not exceed 8 tablets in a 24-hour period.
Benefits Compared to Analogues
Coligaz Chewing Tablets offer a convenient and effective solution for gas-related symptoms, providing rapid relief without systemic absorption, making it suitable for a wide range of patients.
Suitable Patient Groups
Coligaz Chewing Tablets are safe for use in adults and children over 12 years old. Elderly patients and individuals with difficulty swallowing may find these chewable tablets particularly beneficial.
Storage and Shelf Life
Store in a cool, dry place away from direct sunlight. Keep the product out of reach of children. Check the expiration date on the packaging and do not use after the stated shelf life.
Packaging Description
Coligaz Chewing Tablets are available in a package containing 7 tablets. Each tablet is individually sealed to ensure freshness and potency.
Clinical Evidence and Proven Effectiveness
Research has demonstrated the efficacy of simeticone in managing gas-related symptoms. A study in the Journal of Gastroenterology revealed that simeticone effectively reduced bloating and flatulence in patients with irritable bowel syndrome, highlighting its therapeutic benefits.
